Disseminated cryptococcosis with cutaneous lesions

Journal of Dermatology

Volumn 23, Issue 3, 1996, Pages 209-213

  Mostafa, Wedad Z ^a,b   Ishak, Elia Anis ^a   Ekladious, Esmat M ^a   Arnaout, Heba H ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

cryptococcosis; cutaneous; disseminated

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; KETOCONAZOLE; PERMANGANATE POTASSIUM;

ADOLESCENT; ARTICLE; CASE REPORT; CRYPTOCOCCOSIS; DERMATOMYCOSIS; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; EGYPT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION CONTROL; MALE; ORAL DRUG ADMINISTRATION; SKIN DEFECT;

EID: 0029866594     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb03999.x     Document Type: Article

References (17)

1. Wilson RJ, Plunkett OA: Cryptococcosis, in: The Fungous Diseases of Man, University of California Press, Berkley & Los Angeles; 1965, pp 111-129.
2. Angeles AM: Fungal and mycobacterial skin infections, Clinics in Dermatology, 9: 65-69, 1991.
3. Brown JW, Seabury JH: Cryptococcosis, in Demis DJ, Dobson RL, Mcguire J (eds): Clinical Dermatology, 16th revision, Vol. 3, Unit 17, JB Lippincott, Philadelphia, 1989, p 1-10.
4. Penneys N: Cutaneous fungal infections, in Callen JP, Jorizzo J, Greer K, Penneys N, Piette W, Zone JJ (eds): Dermatological Signs of Internal Disease, 2nd ed, WB Saunders, Philadelphia, 1988, pp 255-261.
5. Imwidthaya P, Egtasaeng C: Latex agglutination test for diagnosing Cryptococcosis (abstr), J Med Assoc Thai, 74: 454-458, 1991.
6. Tomecki KJ, Dijkstra JWE, Hall GS, Steck WD: Systemic mycoses, J Am Acad Dermatol, 21: 1285-1293, 1989.
7. Radentz WH: Opportunistic fungal infections in immunocompromised hosts, J Am Acad Dermatol, 20: 989-1003, 1989.
8. Ricchi E, Manfredi R, Scarani P, et al: Cutaneous cryptococcosis and AIDS, J Am Acad Dermatol, 25: 335-336, 1991.
9. Konig M, Grunder K, Nilees M, et al: Cutaneous cryptococcosis as a first symptom of disseminated cryptococcosis in a patient with symphogranulomatosis X, Mycoses, 34: 309-311, 1991.
10. Tomecki KJ, Steck WD, Hall GS, et al: Subcutaneous mycoses, J Am Acad Dermatol, 21: 785-790, 1989.
11. van-Gemert HM, Vermeulen M: Treatment of impaired consciousness with lumbar punctures in a patient with cryptococcal meningitis and AIDS, Clin Neurik-Neurisurg, 93: 257-258, 1991.
12. Polianko NL, Saamov GR: Morphologic manifestations of cutaneous and visceral cryptococcosis (abstr), Arkh Patol, 54: 59-62, 1992.
13. Zarabi MC, Salmassi S: Antermorterm diagnosis of systemic aspergillosis, South Med J, 77: 584-588, 1984. (quoted from ref #1)
14. Oka S, Tokitsu M, Mori H, et al: Clinical evaluation of fluconazole, Japanese Journal of Antibiotics, 42: 31-39, 1989.
15. Saag MS, Powderly WG, Cloud GA, et al: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group, N Engl J Med, 326: 83-89, 1992.
16. Trevisoul-Bittencourt PC, Sander JW, Silvado CS, et al: Ketoconazole in the treatment of cryptococcosis of the central nervous system (abstr), Arg-Neuropsiquiatr, 49: 208-210, 1991.
17. Hay RJ, Roberts SOB, Mackenzie DWR: Mycology, in Champion RH, Burton JL, Eling FJG (eds): Rook Wiklinson Ebling Textbook of Dermatology 5th ed, Blackwell Scientific Bublications, Oxord, 1992, pp 1127-1210.